nach oben

Abdominal Radiology

Erschienen in:

06.11.2017

The role of imaging in the clinical practice of radiation oncology for pancreatic cancer

verfasst von: Eugene J. Koay, William Hall, Peter C. Park, Beth Erickson, Joseph M. Herman

Erschienen in: Abdominal Radiology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Advances in technology have enabled the delivery of high doses of radiation therapy for pancreatic ductal adenocarcinoma (PDAC) with low rates of toxicity. Although the role of radiation for pancreatic cancer continues to evolve, encouraging results with newer techniques indicate that radiation may benefit selected patient populations. Imaging has been central to the modern successes of radiation therapy for PDAC. Here, we review the role of diagnostic imaging, imaging-based planning, and image guidance in radiation oncology practice for PDAC.

Rahib L, Smith BD, Aizenberg R, et al. (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74(11):2913–2921CrossRefPubMed

Iacobuzio-Donahue CA, Fu B, Yachida S, et al. (2009) DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 27(11):1806–1813CrossRefPubMedPubMedCentral

Attiyeh MA, Fernandez-Del Castillo C, Al Efishat M, Eaton AA, Gonen M, Batts R, et al. (2016) Development and validation of a multi-institutional preoperative nomogram for predicting grade of dysplasia in intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: a report from the pancreatic surgery consortium. Ann Surg

Hsu CC, Herman JM, Corsini MM, et al. (2010) Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study. Ann Surg Oncol 17(4):981–990CrossRefPubMedPubMedCentral

Iott M, Neben-Wittich M, Quevedo JF, Miller RC (2010) Adjuvant chemoradiotherapy for resected pancreas cancer. World J Gastrointest Surg 2(11):373–380CrossRefPubMedPubMedCentral

Rwigema JC, Heron DE, Parikh SD, et al. (2012) Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins. J Gastrointest Cancer 43(1):70–76CrossRefPubMed

Mornex F, Girard N, Delpero JR, Partensky C (2005) Radiochemotherapy in the management of pancreatic cancer–part I: neoadjuvant treatment. Semin Radiat Oncol 15(4):226–234CrossRefPubMed

Wei Q, Yu W, Rosati LM, Herman JM (2015) Advances of stereotactic body radiotherapy in pancreatic cancer. Chin J Cancer Res 27(4):349–357PubMedPubMedCentral

Katz MH, Crane CH, Varadhachary G (2014) Management of borderline resectable pancreatic cancer. Semin Radiat Oncol 24(2):105–112CrossRefPubMed

10.

Hammel P, Huguet F, van Laethem JL, et al. (2016) Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial. JAMA 315(17):1844–1853CrossRefPubMed

11.

Loehrer PJ Sr, Feng Y, Cardenes H, et al. (2011) Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol 29(31):4105–4112CrossRefPubMedPubMedCentral

12.

Hammel P, Huguet F, Laethem JL, Goldstein D, Glimelius B, Artru P, et al. (2013) Comparison of chemoradiotherapy and chemotherapy in patients with a locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: final results of the international phase III LAP 07 study. J Clin Oncol suppl; abstr LBA4003

13.

Moningi S, Dholakia AS, Raman SP, et al. (2015) The role of stereotactic body radiation therapy for pancreatic cancer: a single-institution experience. Ann Surg Oncol 22(7):2352–2358CrossRefPubMedPubMedCentral

14.

Krishnan S, Chadha AS, Suh Y, et al. (2016) Focal radiation therapy dose escalation improves overall survival in locally advanced pancreatic cancer patients receiving induction chemotherapy and consolidative chemoradiation. Int J Radiat Oncol Biol Phys 94(4):755–765CrossRefPubMed

15.

Herman JM, Chang DT, Goodman KA, et al. (2015) Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. Cancer 121(7):1128–1137CrossRefPubMed

16.

Herman JM, Hoffman JP, Thayer SP, Wolff RA (2015) Management of the primary tumor and limited metastases in patients with metastatic pancreatic cancer. J Natl Compr Canc Netw 13(5):e29–36CrossRefPubMed

17.

Callery MP, Chang KJ, Fishman EK, et al. (2009) Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 16(7):1727–1733CrossRefPubMed

18.

Gupta S, Wagner-Bartak N, Jensen CT, et al. (2016) Dual-energy CT of pancreatic adenocarcinoma: reproducibility of primary tumor measurements and assessment of tumor conspicuity and margin sharpness. Abdom Radiol (NY) 41(7):1317–1324CrossRef

19.

Fulwadhva UP, Wortman JR, Sodickson AD (2016) Use of dual-energy CT and iodine maps in evaluation of bowel disease. Radiographics 36(2):393–406CrossRefPubMed

20.

Vachiranubhap B, Kim YH, Balci NC, Semelka RC (2009) Magnetic resonance imaging of adenocarcinoma of the pancreas. Top Magn Reson Imaging 20(1):3–9CrossRefPubMed

21.

Park HS, Lee JM, Choi HK, et al. (2009) Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT. J Magn Reson Imaging 30(3):586–595CrossRefPubMed

22.

Kim JH, Park SH, Yu ES, et al. (2010) Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology 257(1):87–96CrossRefPubMed

23.

Farma JM, Santillan AA, Melis M, et al. (2008) PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms. Ann Surg Oncol 15(9):2465–2471CrossRefPubMed

24.

Rijkers AP, Valkema R, Duivenvoorden HJ, van Eijck CH (2014) Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis. Eur J Surg Oncol 40(7):794–804CrossRefPubMed

25.

Chirindel A, Alluri KC, Chaudhry MA, et al. (2015) Prognostic Value of FDG PET/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET/CT Staging. AJR Am J Roentgenol 204(5):1093–1099CrossRefPubMed

26.

Dholakia AS, Chaudhry M, Leal JP, et al. (2014) Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 89(3):539–546CrossRefPubMedPubMedCentral

27.

Evans DB, Varadhachary GR, Crane CH, et al. (2008) Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26(21):3496–3502CrossRefPubMed

28.

Varadhachary GR, Wolff RA, Crane CH, et al. (2008) Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26(21):3487–3495CrossRefPubMed

29.

Katz MH, Ou FS, Herman JM, et al. (2017) Alliance for Clinical Trials in Oncology (ALLIANCE) Trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas. BMC Cancer (accepted)

30.

Crane CH, Koay EJ (2016) Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance. Cancer 122(13):1974–1986CrossRefPubMedPubMedCentral

31.

Elhammali A, Patel M, Weinberg B, et al. (2015) Late gastrointestinal tissue effects after hypofractionated radiation therapy of the pancreas. Radiat Oncol 10:186CrossRefPubMedPubMedCentral

32.

Murimwa G, Mellon EA, Frankes JM, et al. (2017) Impact of duodenal invasion on outcomes in patients with pancreatic cancer treated with stereotactic body radiotherapy. J Clin Oncol (no. 4 suppl):408

33.

Moffitt RA, Marayati R, Flate EL, et al. (2015) Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet 47(10):1168–1178CrossRefPubMedPubMedCentral

34.

Godfrey DJ, Patel BN, Adamson JD, et al. (2017) Triphasic contrast enhanced CT simulation with bolus tracking for pancreas SBRT target delineation. Pract Radiat Oncol. https://doi.org/10.1016/j.prro.2017.04.008 PubMed

35.

Paulson ES, Erickson B, Schultz C, Allen Li X (2015) Comprehensive MRI simulation methodology using a dedicated MRI scanner in radiation oncology for external beam radiation treatment planning. Med Phys 42(1):28–39CrossRefPubMed

36.

Dirix P, Haustermans K, Vandecaveye V (2014) The value of magnetic resonance imaging for radiotherapy planning. Semin Radiat Oncol 24(3):151–159CrossRefPubMed

37.

Arivarasan I, Anuradha C, Subramanian S, Anantharaman A, Ramasubramanian V (2017) Magnetic resonance image guidance in external beam radiation therapy planning and delivery. Jpn J Radiol. https://doi.org/10.1007/s11604-017-0656-5 PubMed

38.

Panych LP, Madore B (2017) The physics of MRI safety. J Magn Reson Imaging. https://doi.org/10.1002/jmri.25761 PubMed

39.

Walker A, Liney G, Metcalfe P, Holloway L (2014) MRI distortion: considerations for MRI based radiotherapy treatment planning. Australas Phys Eng Sci Med 37(1):103–113CrossRefPubMed

40.

Crijns SP, Bakker CJ, Seevinck PR, et al. (2012) Towards inherently distortion-free MR images for image-guided radiotherapy on an MRI accelerator. Phys Med Biol 57(5):1349–1358CrossRefPubMed

41.

Mizowaki T, Nagata Y, Okajima K, et al. (2000) Reproducibility of geometric distortion in magnetic resonance imaging based on phantom studies. Radiother Oncol 57(2):237–242CrossRefPubMed

42.

Basran PS, Woo MK (2008) An analysis of tolerance levels in IMRT quality assurance procedures. Med Phys 35(6):2300–2307CrossRefPubMed

43.

van der Horst A, Wognum S, Davila Fajardo R, et al. (2013) Interfractional position variation of pancreatic tumors quantified using intratumoral fiducial markers and daily cone beam computed tomography. Int J Radiat Oncol Biol Phys 87(1):202–208CrossRefPubMed

44.

Lens E, van der Horst A, Kroon PS, et al. (2014) Differences in respiratory-induced pancreatic tumor motion between 4D treatment planning CT and daily cone beam CT, measured using intratumoral fiducials. Acta Oncol 53(9):1257–1264CrossRefPubMed

45.

Papalazarou C, Klop GJ, Milder MTW, et al. (2017) CyberKnife with integrated CT-on-rails: system description and first clinical application for pancreas SBRT. Med Phys 44:4816CrossRefPubMed

46.

Lagendijk JJ, Raaymakers BW, van Vulpen M (2014) The magnetic resonance imaging-linac system. Semin Radiat Oncol 24(3):207–209CrossRefPubMed

47.

Bissonnette JP, Balter PA, Dong L, et al. (2012) Quality assurance for image-guided radiation therapy utilizing CT-based technologies: a report of the AAPM TG-179. Med Phys 39(4):1946–1963CrossRefPubMed

48.

Jaffray DA (2012) Image-guided radiotherapy: from current concept to future perspectives. Nat Rev Clin Oncol 9(12):688–699CrossRefPubMed

49.

Pereira GC, Traughber M, Muzic RF Jr (2014) The role of imaging in radiation therapy planning: past, present, and future. Biomed Res Int 2014:231090PubMedPubMedCentral

50.

Kupelian P, Sonke JJ (2014) Magnetic resonance-guided adaptive radiotherapy: a solution to the future. Semin Radiat Oncol 24(3):227–232CrossRefPubMed

51.

Goddu S, Green OP, Mutic S (2012) WE-G-BRB-08: TG-51 calibration of first commercial MRI-guided IMRT system in the presence of 0.35 Tesla magnetic field. Med Phys 39(6Part28):3968CrossRefPubMed

52.

Jaffray D, Mutic S, Fallone B, Raaymakers B (2013) MO-A-WAB-01: MRI-guided radiation therapy. Med Phys 40(6Part23):390CrossRef

53.

Mutic S, Dempsey JF (2014) The ViewRay system: magnetic resonance-guided and controlled radiotherapy. Semin Radiat Oncol 24(3):196–199CrossRefPubMed

54.

Tzeng CW, Fleming JB, Lee JE, et al. (2012) Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. HPB (Oxford) 14(6):365–372CrossRef

55.

St Aubin J, Steciw S, Fallone BG (2010) The design of a simulated in-line side-coupled 6 MV linear accelerator waveguide. Med Phys 37(2):466–476CrossRefPubMed

56.

Fallone BG (2014) The rotating biplanar linac-magnetic resonance imaging system. Semin Radiat Oncol 24(3):200–202CrossRefPubMed

57.

Keyvanloo A, Burke B, St Aubin J, et al. (2016) Minimal skin dose increase in longitudinal rotating biplanar linac-MR systems: examination of radiation energy and flattening filter design. Phys Med Biol 61(9):3527–3539CrossRefPubMed

58.

Keall PJ, Barton M, Crozier S, Australian Mri-Linac Program icfIIICCCLHSUUoNQSWS, Wollongong (2014) The Australian magnetic resonance imaging-linac program. Semin Radiat Oncol 24(3):203–206CrossRefPubMed

59.

Whelan B, Gierman S, Holloway L, et al. (2016) A novel electron accelerator for MRI-Linac radiotherapy. Med Phys 43(3):1285–1294CrossRefPubMedPubMedCentral

60.

Aguilera KY, Rivera LB, Hur H, et al. (2014) Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma. Cancer Res 74(4):1032–1044CrossRefPubMed

61.

Bol GH, Hissoiny S, Lagendijk JJ, Raaymakers BW (2012) Fast online Monte Carlo-based IMRT planning for the MRI linear accelerator. Phys Med Biol 57(5):1375–1385CrossRefPubMed

62.

Raaymakers BW, Lagendijk JJ, Overweg J, et al. (2009) Integrating a 1.5 T MRI scanner with a 6 MV accelerator: proof of concept. Phys Med Biol 54(12):N229–237CrossRefPubMed

Titel: The role of imaging in the clinical practice of radiation oncology for pancreatic cancer
verfasst von: Eugene J. Koay
William Hall
Peter C. Park
Beth Erickson
Joseph M. Herman
Publikationsdatum: 06.11.2017
Verlag: Springer US
Erschienen in: Abdominal Radiology / Ausgabe 2/2018
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-017-1373-3

Neu im Fachgebiet Radiologie

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The role of imaging in the clinical practice of radiation oncology for pancreatic cancer

Abstract

Neu im Fachgebiet Radiologie

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Update Radiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma

Extrapancreatic perineural invasion in pancreatic adenocarcinoma

Radiologic evaluation of patients undergoing the modified Appleby procedure for locally advanced pancreatic neoplasms: a case series

Medical oncology and pancreatic cancer: what the radiologist needs to know

Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease

Pancreatic adenocarcinoma: cross-sectional imaging techniques

Neu im Fachgebiet Radiologie

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Update Radiologie